Micromedic Announces routine use of CellDetect in additional CLIA Laboratory in the US

Micromedic announces routine use of CellDetect® in additional CLIA laboratory in the US

 

Micromedic Technologies announced additional CLIA laboratory in the US to use CellDetect® staining platform as a routine diagnostic test to detect bladder cancer.

The laboratory has conducted a validaion study, comparing CellDetect® to other technologies, in 80 patients. The study showed enhanced sensitivity of CellDetect compared to the other methods.

Link to complete article (Hebrew) 

More News/Information
© Micromedic Technologies Ltd. site mapcontact
 
Site by Site2goal | Design Studio Michal Lehavi